<DOC>
	<DOCNO>NCT00405080</DOCNO>
	<brief_summary>This study examine body take GW679769 alone together rifampin healthy adult subject .</brief_summary>
	<brief_title>A Study Healthy Subjects Assess How Dosing Rifampin Affects What Body Does Dose GW679769 ( Casopitant ) .</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criterion : healthy female subject become pregnant able swallow keep oral medication understand follow protocol requirement instruction Exclusion criterion : smoke least 4 pack per day past 12 month use prescription nonprescription drug ( ) herbal dietary supplement vitamins 14 day prior first dose study medication clinically relevant abnormality medical condition circumstance make subject unsuitable study per study doctor blood donation excess 1 pint within 56 day dose medication iron deficient history drug allergy study medication history drug alcohol abuse dependency within past 6 month subject use nicotinecontaining product within last 6 month positive HIV , Hepatitis B C active peptic ulcer disease uncontrolled nausea vomit active infection heart failure female lactate female positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Rifampin GW679769</keyword>
</DOC>